Smith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring System

(RTTNews) - Smith+Nephew (SN.L, SNN) said its wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with over 7 million hours of use. A randomized clinical trial conducted using the LEAF System showed that hospital acquired pressure injury odds were reduced by 73%.

First deployed in healthcare facilities in 2014, the LEAF System was the first FDA-cleared device to monitor patient orientation and activity in bed-bound, chair-bound, and ambulatory patients. The LEAF System helps measure turn frequency, turn angle and tissue recovery time to improve patient repositioning.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.